PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 12 filers reported holding PROVENTION BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 287,172 | $4,052,000 | 3.32% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,124,973 | $15,873,000 | 3.12% |
| Perceptive Advisors | 4,525,711 | $63,858,000 | 1.04% |
| 683 Capital Management, LLC | 600,000 | $8,467,000 | 0.68% |
| Monashee Investment Management LLC | 250,000 | $3,528,000 | 0.53% |
| Soleus Capital Management, L.P. | 59,900 | $845,000 | 0.48% |
| EAM Global Investors LLC | 69,564 | $982,000 | 0.44% |
| EAM Investors, LLC | 54,020 | $762,000 | 0.17% |
| Virtus ETF Advisers LLC | 24,401 | $344,000 | 0.16% |
| GILDER GAGNON HOWE & CO LLC | 1,251,260 | $17,655,000 | 0.14% |